Contact Us

Resources

Publication: Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models

View or download the Publication to read more
The treatment of von Willebrand disease (VWD) has remained basically unchanged for the past 30 years. However, these different approaches do not consider the heterogeneity of VWD and so far, no type or subtype-specific treatment option has been developed. In this study, a BioFlux shear flow system was used to assess platelet aggregation and thrombus formation. With the help of a BioFlux, the investigators were able to determine that synthetic platelet nanoparticles were effective at enhancing clotting in mice with VWD.

Related Resources

Distinct and convergent effects of SF3B1 mutations in human breast cancer

In this study, CellRaft AIR was used to isolate, verify, and expand monoclonal cell lines carrying engineered SF3B1 mutations, forming the basis of an isogenic...

Learn more

A benchmark of the somatic mutation landscape using single-cell and single-molecule whole-genome sequencing

In this work, CellRaft arrays were used to generate clonally derived cell populations from single cells prior to sequencing, providing a ground-truth reference for benchmarking...

Learn more

Loss of cell cycle gatekeeping by CNOT3 impairs hematopoietic stem and progenitor cell division and repopulating activity

In this study, CellRaft AIR was used to isolate and track single hematopoietic stem and progenitor cell (HSPC) clones over time, enabling researchers to directly...

Learn more
See all Publications